Fractyl Health Inc. (NASDAQ: GUTS) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT FRACTYL HEALTH INC.

Fractyl Health Inc. (NASDAQ: GUTS)
Listen to this Section


$0.67
-0.0646 ( -8.81% ) 2.3M

Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.

Clinical Trial Pipeline Stages


Drug Name Stage
RevitaDetailsObesity, Type 2 diabetes Phase 1

Market Data


Open $0.67
Previous Close $0.73
Volume 2.3M
Market Cap $120.57M
Day Range $0.66 - $0.77
52 Week Range $0.38 - $3.03
Shares Outstanding 158.65M
Change % -8.81%
Net Change ▼ -0.0646
Insider Ownership -0.05%
Exchange NASDAQ
SectorHealthcare
Industry
IPO Year2024
CountryUnited States
UnderwriterBofA Securities, Morgan Stanley, Evercore ISI, more

Insider Ownership Transactions

Total Amount Purchased: 2,350,947.00

Date Type Amount Purchased Purchaser
2024-04-02 Sale -250000.00 Kimber Adrian
2024-02-08 Sale -4770901.00 Bessemer Venture Partners VII L.P.
2024-02-08 Buy 1389451.00 Elia Marc
2024-02-08 Buy 5160301.00 Royan Ajay
2024-02-08 Sale -23299.00 Caplan Jay David
2024-02-08 Sale -673391.00 Corebridge DECO II, LLC
2024-02-08 Sale -283878.00 AMERICAN HOME ASSURANCE CO
2024-02-08 Sale -277890.00 MEANWELL CLIVE
2024-02-08 Sale -6523.00 Rajagopalan Harith
2024-02-08 Buy 5160301.00 Mithril LP

SEC Filings


Form Type Description Pages Date
3 Insider transactions 2 Sep 04, 2025
4 Insider transactions 1 Sep 04, 2025
4 Insider transactions 1 Sep 04, 2025
8-k 8K-related 10 Sep 03, 2025
def Proxies and info statements 7 Aug 25, 2025
pre Proxies and info statements 4 Aug 15, 2025
10-q Quarterly Reports 62 Aug 12, 2025
8-k 8K-related 12 Aug 12, 2025
8-k 8K-related 20 Aug 07, 2025
8-k 8K-related 12 Jun 23, 2025

Latest News


× Before browsing our site, please accept our cookies policy